Clinical trial
Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Pathologic Myopia
NCT04976244 is registered in ClinicalTrials.gov with The Filatov Institute of Eye Diseases and Tissue Therapy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Pathologic Myopia
- Lead sponsor
- The Filatov Institute of Eye Diseases and Tissue Therapy
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2021
- Completion date
- April 1, 2022
- Enrollment
- 50 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
pathologic myopia